The BRAIN AG will implement technologies developed by the AutoBio project into an existing robot system to automatize high-throughput screenings. By identifying and optimising expression strains, artificial pathway assemblies and enzyme screenings (metagenomes) an increased efficiency in developing bioprocesses is to be demonstrated. The BRAIN AG belongs to the technologically leading companies in Europe in the field of “white” biotechnology. Within the scope of strategic cooperation innovative products and solutions are identified and developed for industrial enterprises. These products and solutions for the chemistry, pharmacology, cosmetic and foodstuff are based on naturally existing but not yet explored biological solutions. Today 102 highly qualified employees work for the BRAIN AG.